The rise of pronatalism: why Musk, Vance and the right want women to have more babies
By Carter Sherman,
The Guardian
| 03. 11. 2025
In his first address to the United States after becoming vice-president, JD Vance stood on stage and proclaimed: “I want more babies in the United States of America.” Weeks later, Donald Trump signed an executive order pledging support for in vitro fertilization, recognizing “the importance of family formation and that our nation’s public policy must make it easier for loving and longing mothers and fathers to have children”.
In late January, a Department of Transportation memo directed the agency to prioritize projects that “give preference to communities with marriage and birth rates higher than the national average”. And last week, it was reported that Elon Musk, the unelected head of the government-demolishing “department of governmental efficiency” and a man who has said that the “collapsing birth rate is the biggest danger civilization faces by far”, had become a father of 14.
Republicans have long heralded the importance of “family values”. But in these developments, many see mounting signs of a controversial ideology at work: pronatalism.
Pronatalism is so contentious that people often struggle to agree...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...